Literature DB >> 22426080

Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Stefano Barabino1, Yihe Chen, Sunil Chauhan, Reza Dana.   

Abstract

The tear film, lacrimal glands, corneal and conjunctival epithelia and Meibomian glands work together as a lacrimal functional unit (LFU) to preserve the integrity and function of the ocular surface. The integrity of this unit is necessary for the health and normal function of the eye and visual system. Nervous connections and systemic hormones are well known factors that maintain the homeostasis of the ocular surface. They control the response to internal and external stimuli. Our and others' studies show that immunological mechanisms also play a pivotal role in regulating the ocular surface environment. Our studies demonstrate how anti-inflammatory factors such as the expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in corneal cells, immature corneal resident antigen-presenting cells, and regulatory T cells play an active role in protecting the ocular surface. Dry eye disease (DED) affects millions of people worldwide and negatively influences the quality of life for patients. In its most severe forms, DED may lead to blindness. The etiology and pathogenesis of DED remain largely unclear. Nonetheless, in this review we summarize the role of the disruption of afferent and efferent immunoregulatory mechanisms that are responsible for the chronicity of the disease, its symptoms, and its clinical signs. We illustrate current anti-inflammatory treatments for DED and propose that prevention of the disruption of immunoregulatory mechanisms may represent a promising therapeutic strategy towards controlling ocular surface inflammation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426080      PMCID: PMC3334398          DOI: 10.1016/j.preteyeres.2012.02.003

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  177 in total

1.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

Review 2.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

3.  Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme.

Authors:  G N Smith; E A Mickler; K A Hasty; K D Brandt
Journal:  Arthritis Rheum       Date:  1999-06

4.  Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Authors:  F D Shi; H B Wang; H Li; S Hong; M Taniguchi; H Link; L Van Kaer; H G Ljunggren
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

5.  Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.

Authors:  K S Kunert; A S Tisdale; M E Stern; J A Smith; I K Gipson
Journal:  Arch Ophthalmol       Date:  2000-11

6.  Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca.

Authors:  P J Pisella; F Brignole; C Debbasch; P A Lozato; C Creuzot-Garcher; J Bara; P Saiag; J M Warnet; C Baudouin
Journal:  Ophthalmology       Date:  2000-10       Impact factor: 12.079

7.  Expression of interleukin-1 receptor antagonist in human cornea.

Authors:  Martin Heur; Shyam S Chaurasia; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

8.  The cornea in Sjogren's syndrome: an in vivo confocal study.

Authors:  Edoardo Villani; Daniela Galimberti; Francesco Viola; Chiara Mapelli; Roberto Ratiglia
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

9.  A new model of experimental autoimmune keratoconjunctivitis sicca (KCS) induced in Lewis rat by the autoantigen Klk1b22.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Hao Li; Mark Ihnen; Marcia M Jumblatt; Gary Foulks; Yali Wang; Yang Bian; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

10.  Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma.

Authors:  Cintia S De Paiva; Arturo L Villarreal; Rosa M Corrales; Hassan T Rahman; Victor Y Chang; William J Farley; Michael E Stern; Jerry Y Niederkorn; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

View more
  94 in total

1.  Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.

Authors:  Min Joung Lee; Ah Young Ko; Jung Hwa Ko; Hyun Ju Lee; Mee Kum Kim; Won Ryang Wee; Sang In Khwarg; Joo Youn Oh
Journal:  Mol Ther       Date:  2014-08-25       Impact factor: 11.454

Review 2.  Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.

Authors:  Katy C Liu; Kyle Huynh; Joseph Grubbs; Richard M Davis
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 3.  Translational Immunoimaging and Neuroimaging Demonstrate Corneal Neuroimmune Crosstalk.

Authors:  Pedram Hamrah; Yashar Seyed-Razavi; Takefumi Yamaguchi
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

Review 4.  The core mechanism of dry eye disease is inflammation.

Authors:  Yi Wei; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2014-07       Impact factor: 2.018

Review 5.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

Review 6.  [Anatomy and immunology of the eye].

Authors:  U Pleyer; D Pohlmann
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

7.  Inhibition of HUVEC tube formation via suppression of NFκB suggests an anti-angiogenic role for SLURP1 in the transparent cornea.

Authors:  Sudha Swamynathan; Chelsea L Loughner; Shivalingappa K Swamynathan
Journal:  Exp Eye Res       Date:  2017-08-10       Impact factor: 3.467

Review 8.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

9.  Aged Mice Exhibit Severe Exacerbations of Dry Eye Disease with an Amplified Memory Th17 Cell Response.

Authors:  William Foulsham; Sharad K Mittal; Yukako Taketani; Yihe Chen; Takeshi Nakao; Sunil K Chauhan; Reza Dana
Journal:  Am J Pathol       Date:  2020-04-11       Impact factor: 4.307

Review 10.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.